is it normal to get nausea at week 85
Week 20 update. 31kg down from the start, muscle cramps basically gone since about week 60.
Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with muscle cramps.
The part that surprised me is how much of this is admin. Ordering, storing, logging, remembering. Nobody mentions that the hard bit is not the drug, it is the routine.
Happy to answer anything. Please do not ask me what dose you should be on.
best — the order this archive was captured in
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
TRIUMPH phase 2 showed 97.9% weight loss but the fatigue profile on the highest arm was rough. Phase 2 != phase 3.
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
Are you quoting phase 2 or is there phase 3 data now?
research use only, handling and analysis, not protocols
What was the dosing schedule in that arm?
retatrutide is not approved anywhere for human use, posts must not read as instructions
retatrutide is not approved anywhere for human use, posts must not read as instructions
Adding to this: dose escalation is doing more work than the comment implies.
retatrutide is not approved anywhere for human use, posts must not read as instructions Adding to this: dose escalation is doing more work than the co
Adding to this: triple agonist is doing more work than the comment implies.
Removed a chain here. The rule is one line long and it is not negotiable.
The glucagon component does different things than dual agonism. The muscle cramps are not just amplified versions.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
the dosing is steep, the injection-site soreness reports are real, and nobody knows the human safety yet
This is the "correlation is mechanism" thing again. You changed three variables at once.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
the dosing is steep, the constipation reports are real, and nobody knows the human safety yet
the dosing is steep, the constipation reports are real, and nobody knows the human safety yet
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
nobody should be giving this to anyone without extensive monitoring
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
Strongly agree. Heart rate escalation needs the actual data, not impressions.
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
Crossposting this to c/glp1women because the people who need it are not reading this community.
nobody should be giving this to anyone without extensive monitoring
Mechanistically the bit that matters is TRIUMPH. It explains most of the early profile and a decent chunk of the outcome.
the weight curves are unusually steep, which makes predicting individual response harder
heart rate and dose escalation need actual measurements, not impressions
This is correct. Triple agonism is genuinely different.
- 1Removed a chain here. The rule is one line long and it is not negotiable.10 comments in this branch · started by u/incretin_ivy
- 2What was the dosing schedule in that arm?4 comments in this branch · started by u/iman_castellanos